The prpose is to study clinical efficiency of the combined drug GeniusPlus among the patients with psychoemotional and vegetative disorders at initial manifestations of chronic cerebral ischemia (IMCCI).
Materials and methods of investigation. There were examined 65 patients with the IMCCI, among them there were 40 women and 25 men. Etiological factors of the disease were cerebral arteriosclerosis in combination with arterial hypertension. The average age was 43.0 (40.0– 48.0) years. Patients were divided into 2 groups depending on the treatment management: basic (n=35) and control (n=30). Patients of the main group took Genius Plus by 1 capsule three times a day during 2 months. The patients of the main and control groups received basic therapy that included antihypertensive and lipid-lowering drugs (for medical reasons). Also, there were recommended daily exercise, healthy diet, following the schedule of work and rest, sleep hygiene. Patients of both groups were not taking drugs with psychotropic action (antidepressants, tranquilizers, anticonvulsants, Phenibut) and didn’t have any bad habits. Groups were compared to their age, sex, education level and clinical disease.
Results and conclusions. After the treatment with the help of Genius Plus the number of complains of headache, sleep disturbances, irritability, fatigue and performance decrement were reduced. From the other hand, attention and memory were improved. After Genius Plus usage patients with psychoemotional and vegetative disorders were diagnosed with decreased manifestations of autonomic dysfunction, improvement of psychoemotional state that was estimated due to the Spielberger-Khanin anxiety test, asthenic state scales and Beck depression inventory, which was confirmed by a significant decrease of the total score for each test. Also, it was observed an improvement of active attention expressed as a reduced average time of a search of numbers due to the Schulte tables and verbal memory according to Luria’s test.